Recombinant Human DPP4/CD26 (HEK293, C-6His)  别名:Dipeptidyl Peptidase 4; DPP IV; ADCP-2; 重组人DPP4/CD26 (HEK293, C-6His)

目录号 M55024

DPP4/CD26 is a signal-anchor for type II membrane protein that belongs to the peptidase S9B family. DPP4/CD26 acts as a positive regulator of T-cell coactivation, by binding at least ADA, CAV1, IGF2R, and PTPRC. It’s binding to CAV1 and CARD11 induces T-cell proliferation and NF-kappa-B activation in a T-cell receptor/CD3-dependent manner.

Recombinant Human DPP4/CD26 (HEK293, C-6His)结构式

 

规格 价格 库存状态
10ug ¥ 1755 现货
50ug ¥ 4950 现货
本产品不参加促销活动    
*AbMole所有产品仅供有资质的科研机构或医药企业进行科学研究或药证申报用途,不能被用于人体和任何其它用途。我们不向任何个人或非科研性质的机构提供产品和服务。
质量标准及产品资料
  • 纯度:>95%, Endotoxin < 1 EU/µg
  • COA
化学性质/溶解性/储存
性状 Lyophilized powder
中文名称 重组人DPP4/CD26 (HEK293, C-6His)
溶解性 Reconstitute the lyophilized powder in distilled water up to 100 μg/ml.
储存条件 Stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days and at -20°C for 3 months.
运输方式 冰袋运输,根据产品的不同,可能会有相应调整。
生物活性

DPP4/CD26 is a signal-anchor for type II membrane protein that belongs to the peptidase S9B family. DPP4/CD26 acts as a positive regulator of T-cell coactivation, by binding at least ADA, CAV1, IGF2R, and PTPRC. It's binding to CAV1 and CARD11 induces T-cell proliferation and NF-kappa-B activation in a T-cell receptor/CD3-dependent manner. It acts also as a serine exopeptidase with a dipeptidyl peptidase activity that regulates various physiological processes by cleaving peptides in the circulation, including many chemokines, mitogenic growth factors, neuropeptides and peptide hormones.

Recombinant Human Dipeptidyl Peptidase 4 expressed the target gene encoding Asn29-Pro766 with a 6His tag at the C-terminus.


Accession: P27487

Endotoxin < 1 EU/µg

Apparent Molecular Weight: 90-130 KDa, reducing conditions

Lyophilized from a 0.2 μm filtered solution of 20mM Tris-HCl, 10% Trehalose, 100mM NaCl, 0.05% Tween 80, pH 8.5.

实验参考
动物实验

建议您制定动物给药及实验方案时,尽量参考已发表的相关实验文献(溶剂种类及配比众多,简单地溶解目的化合物,并不能解决动物给药依从性、体内生物利用度、组织分布等相关问题,未必能保证目的化合物在动物体内充分发挥生物学效用)。
体内实验的工作液,建议您现用现配,当天使用;如在配制过程中出现沉淀、析出现象,可以通过超声和(或)加热的方式助溶。
切勿一次性将产品全部溶解。


动物实验方案计算器

请在下面的计算器中,输入您的动物实验相关数据并点击计算,即可得到该实验的总需药量和工作液终浓度。
例如您给药剂量是10 mg/kg,平均每只动物的体重为20 g,每只动物的给药体积是100 μL,动物数量为20只,则该动物实验的总需药量为4 mg,工作液终浓度为2 mg/mL。

mg/kg
uL
该动物实验的总需药量为 mg
工作液终浓度2 mg/mL

1:鉴于实验过程的损耗,建议您至少多配1-2只动物的量;
2:为该产品最终给药时的浓度。






关键词:Recombinant Human DPP4/CD26 (HEK293, C-6His), Dipeptidyl Peptidase 4; DPP IV; ADCP-2, Recombinant Human DPP4/CD26 (HEK293, C-6His)供应商, Cytokines and Growth Factors抑制剂, 购买Recombinant Human DPP4/CD26 (HEK293, C-6His), Recombinant Human DPP4/CD26 (HEK293, C-6His)溶解度, Recombinant Human DPP4/CD26 (HEK293, C-6His)结构式







产品仅供科学研究或药证申报的用途使用,不为任何个人或者非科研性质的其他用途提供服务。

Copyright © 2010-2025 AbMole版权所有